NO20012534L - Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering - Google Patents

Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering

Info

Publication number
NO20012534L
NO20012534L NO20012534A NO20012534A NO20012534L NO 20012534 L NO20012534 L NO 20012534L NO 20012534 A NO20012534 A NO 20012534A NO 20012534 A NO20012534 A NO 20012534A NO 20012534 L NO20012534 L NO 20012534L
Authority
NO
Norway
Prior art keywords
cells
migration
parvoviral capsid
inhibition
cell proliferation
Prior art date
Application number
NO20012534A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012534D0 (no
Inventor
Kristina Broliden
Magnus Westgren
Original Assignee
Magnus Westgren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magnus Westgren filed Critical Magnus Westgren
Publication of NO20012534D0 publication Critical patent/NO20012534D0/no
Publication of NO20012534L publication Critical patent/NO20012534L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20012534A 1998-11-24 2001-05-23 Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering NO20012534L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804022A SE520177C2 (sv) 1998-11-24 1998-11-24 Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller
PCT/IB1999/002112 WO2000030668A2 (en) 1998-11-24 1999-11-23 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration

Publications (2)

Publication Number Publication Date
NO20012534D0 NO20012534D0 (no) 2001-05-23
NO20012534L true NO20012534L (no) 2001-06-29

Family

ID=20413393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012534A NO20012534L (no) 1998-11-24 2001-05-23 Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering

Country Status (14)

Country Link
EP (1) EP1131085A2 (is)
JP (1) JP2003516927A (is)
KR (1) KR20010080518A (is)
CN (1) CN1328469A (is)
AU (1) AU2566600A (is)
CA (1) CA2352043A1 (is)
CZ (1) CZ20011369A3 (is)
HU (1) HUP0104298A2 (is)
IS (1) IS5931A (is)
MX (1) MXPA01004949A (is)
NO (1) NO20012534L (is)
PL (1) PL348640A1 (is)
SE (1) SE520177C2 (is)
WO (1) WO2000030668A2 (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124523T2 (de) 2001-07-10 2007-09-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse
EP1791858B1 (en) * 2004-09-24 2010-04-21 Intercell AG Modified vp1-capsid protein of parvovirus b19
CN101475942B (zh) * 2008-11-28 2012-05-23 中国人民解放军第四军医大学 一种b19病毒vp1独特区基因
US9598468B2 (en) 2011-05-18 2017-03-21 University Of Florida Research Foundation, Incorporated Polypeptides and vectors for targeting HER2/neu expressing cells and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002839C (en) * 1988-11-14 2000-10-10 Neal S. Young Parvovirus capsids
NL8902301A (nl) * 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.

Also Published As

Publication number Publication date
CZ20011369A3 (cs) 2001-10-17
JP2003516927A (ja) 2003-05-20
WO2000030668A3 (en) 2000-11-09
AU2566600A (en) 2000-06-13
CA2352043A1 (en) 2000-06-02
WO2000030668A9 (en) 2001-04-05
PL348640A1 (en) 2002-06-03
CN1328469A (zh) 2001-12-26
IS5931A (is) 2001-05-02
EP1131085A2 (en) 2001-09-12
KR20010080518A (ko) 2001-08-22
SE9804022L (sv) 2000-05-25
WO2000030668A8 (en) 2000-09-14
HUP0104298A2 (hu) 2002-03-28
NO20012534D0 (no) 2001-05-23
SE520177C2 (sv) 2003-06-03
WO2000030668A2 (en) 2000-06-02
SE9804022D0 (sv) 1998-11-24
MXPA01004949A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
Piera‐Velazquez et al. Increased life span of human osteoarthritic chondrocytes by exogenous expression of telomerase
Kang et al. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres
Cummins et al. HAUSP is required for p53 destabilization
Lalueza‐Fox et al. Mitochondrial DNA from pre‐Columbian Ciboneys from Cuba and the prehistoric colonization of the Caribbean
Roche et al. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature
Solana et al. Molecular and cellular basis of immunosenescence
EP1610722A4 (en) APPARATUS FOR RE-ESTABLISHING VALVULAR AORTIC FUNCTION AND METHOD OF TREATMENT USING THE SAME
Sanford et al. A quest for the mechanism of “spontaneous” malignant transformation in culture with associated advances in culture technology
Stellavato et al. [Retracted] Novel Hybrid Gels Made of High and Low Molecular Weight Hyaluronic Acid Induce Proliferation and Reduce Inflammation in an Osteoarthritis In Vitro Model Based on Human Synoviocytes and Chondrocytes
BR112022004562A2 (pt) Método de seleção de doador universal para identificar doadores de células nk
Lin et al. Three dimensional culture of potential epithelial progenitor cells in human lacrimal gland
Yang et al. l‐Glutathione enhances antioxidant capacity of hyaluronic acid and modulates expression of pro‐inflammatory cytokines in human fibroblast‐like synoviocytes
Ruef et al. Granulocyte-macrophage colony-stimulating factor-dependent CD11c-positive cells differentiate into active osteoclasts
Longley et al. The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells
Rakonczay Jr et al. Chronic inflammation in the pancreas and salivary glands-lessons from similarities and differences in pathophysiology and treatment modalities
Zhang et al. RSK-3 promotes cartilage regeneration via interacting with rpS6 in cartilage stem/progenitor cells
WO2022192249A3 (en) Compositions and methods for assessing and treating t cell dysfunction
Gorunova et al. Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations
BR112022003045A2 (pt) Métodos para determinar a adequação de tecido de timo cultivado para o implante em humanos e métodos de uso associados
Mahiddine et al. CD99 isoforms regulate CD1a expression in human monocyte‐derived DCs through ATF‐2/CREB‐1 phosphorylation
KR20190013465A (ko) 코 하비갑개 유래 중간엽 줄기세포를 유효성분으로 포함하는 류마티스 관절염 예방 또는 치료용 약학적 조성물
SE9804022D0 (sv) Use of a parvovirus capsid particles in the inhibition of hematopoietic progenitor cells
Parkinson Telomerase as a novel and potentially selective target for cancer chemotherapy
Yuan et al. Chondrogenic differentiation and immunological properties of mesenchymal stem cells in collagen type I hydrogel
Yao et al. In vitro study of chondrocyte redifferentiation with lentiviral vector‐mediated transgenic TGF‐β3 and shRNA suppressing type I collagen in three‐dimensional culture

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application